Covid-19 Impact on Global Viral Vector and Plasmid DNA Market Size, Status and Forecast 2020-2026

    • ID: AR2932574
    • 27 May, 2020
    • Other
    • Region: Global
    • 132 Pages
    • QYResearch

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Viral Vector and Plasmid DNA Revenue
    • 1.4 Covid-19 Implications on Market by Type
      • 1.4.1 Global Viral Vector and Plasmid DNA Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Plasmid DNA
      • 1.4.3 Viral Vector
    • 1.5 Market by Application
      • 1.5.1 Global Viral Vector and Plasmid DNA Market Share by Application: 2020 VS 2026
      • 1.5.2 Cancer
      • 1.5.3 Virus Infection
      • 1.5.4 Hereditary Disease
    • 1.6 Coronavirus Disease 2019 (Covid-19): Viral Vector and Plasmid DNA Industry Impact
      • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
      • 1.6.2 Covid-19 Impact: Commodity Prices Indices
      • 1.6.3 Covid-19 Impact: Global Major Government Policy
    • 1.7 Study Objectives
    • 1.8 Years Considered

    2 Global Growth Trends

    • 2.1 Covid-19 Implications on Global Viral Vector and Plasmid DNA Market Perspective (2015-2026)
    • 2.2 Covid-19 Implications on Global Viral Vector and Plasmid DNA Growth Trends by Regions
      • 2.2.1 Viral Vector and Plasmid DNA Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Viral Vector and Plasmid DNA Historic Market Share by Regions (2015-2020)
      • 2.2.3 Viral Vector and Plasmid DNA Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Viral Vector and Plasmid DNA Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Viral Vector and Plasmid DNA Players (Opinion Leaders)

    3 Covid-19 Implications on Competition Landscape by Key Players

    • 3.1 Global Top Viral Vector and Plasmid DNA Players by Market Size
      • 3.1.1 Global Top Viral Vector and Plasmid DNA Players by Revenue (2015-2020)
      • 3.1.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Viral Vector and Plasmid DNA Market Concentration Ratio
      • 3.2.1 Global Viral Vector and Plasmid DNA Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Viral Vector and Plasmid DNA Revenue in 2019
    • 3.3 Viral Vector and Plasmid DNA Key Players Head office and Area Served
    • 3.4 Key Players Viral Vector and Plasmid DNA Product Solution and Service
    • 3.5 Date of Enter into Viral Vector and Plasmid DNA Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Covid-19 Implications on Market Size by Type (2015-2026)

    • 4.1 Global Viral Vector and Plasmid DNA Historic Market Size by Type (2015-2020)
    • 4.2 Global Viral Vector and Plasmid DNA Forecasted Market Size by Type (2021-2026)

    5 Covid-19 Implications on Market Size by Application (2015-2026)

    • 5.1 Global Viral Vector and Plasmid DNA Market Size by Application (2015-2020)
    • 5.2 Global Viral Vector and Plasmid DNA Forecasted Market Size by Application (2021-2026)

    6 North America Impact of COVID-19

    • 6.1 North America Viral Vector and Plasmid DNA Market Size (2015-2020)
    • 6.2 Viral Vector and Plasmid DNA Key Players in North America (2019-2020)
    • 6.3 North America Viral Vector and Plasmid DNA Market Size by Type (2015-2020)
    • 6.4 North America Viral Vector and Plasmid DNA Market Size by Application (2015-2020)

    7 Europe Impact of COVID-19

    • 7.1 Europe Viral Vector and Plasmid DNA Market Size (2015-2020)
    • 7.2 Viral Vector and Plasmid DNA Key Players in Europe (2019-2020)
    • 7.3 Europe Viral Vector and Plasmid DNA Market Size by Type (2015-2020)
    • 7.4 Europe Viral Vector and Plasmid DNA Market Size by Application (2015-2020)

    8 China Impact of COVID-19

    • 8.1 China Viral Vector and Plasmid DNA Market Size (2015-2020)
    • 8.2 Viral Vector and Plasmid DNA Key Players in China (2019-2020)
    • 8.3 China Viral Vector and Plasmid DNA Market Size by Type (2015-2020)
    • 8.4 China Viral Vector and Plasmid DNA Market Size by Application (2015-2020)

    9 Japan Impact of COVID-19

    • 9.1 Japan Viral Vector and Plasmid DNA Market Size (2015-2020)
    • 9.2 Viral Vector and Plasmid DNA Key Players in Japan (2019-2020)
    • 9.3 Japan Viral Vector and Plasmid DNA Market Size by Type (2015-2020)
    • 9.4 Japan Viral Vector and Plasmid DNA Market Size by Application (2015-2020)

    10 India Impact of COVID-19

    • 10.1 India Viral Vector and Plasmid DNA Market Size (2015-2020)
    • 10.2 Viral Vector and Plasmid DNA Key Players in India (2019-2020)
    • 10.3 India Viral Vector and Plasmid DNA Market Size by Type (2015-2020)
    • 10.4 India Viral Vector and Plasmid DNA Market Size by Application (2015-2020)

    11Key Players Profiles

    • 11.1 Brammer Bio
      • 11.1.1 Brammer Bio Company Details
      • 11.1.2 Brammer Bio Business Overview and Its Total Revenue
      • 11.1.3 Brammer Bio Viral Vector and Plasmid DNA Introduction
      • 11.1.4 Brammer Bio Revenue in Viral Vector and Plasmid DNA Business (2015-2020))
      • 11.1.5 Brammer Bio Recent Development and Reaction to COVID-19
    • 11.2 Oxford BioMedica
      • 11.2.1 Oxford BioMedica Company Details
      • 11.2.2 Oxford BioMedica Business Overview and Its Total Revenue
      • 11.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Introduction
      • 11.2.4 Oxford BioMedica Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 11.2.5 Oxford BioMedica Recent Development and Reaction to COVID-19
    • 11.3 Cobra Biologics
      • 11.3.1 Cobra Biologics Company Details
      • 11.3.2 Cobra Biologics Business Overview and Its Total Revenue
      • 11.3.3 Cobra Biologics Viral Vector and Plasmid DNA Introduction
      • 11.3.4 Cobra Biologics Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 11.3.5 Cobra Biologics Recent Development and Reaction to COVID-19
    • 11.4 FinVector
      • 11.4.1 FinVector Company Details
      • 11.4.2 FinVector Business Overview and Its Total Revenue
      • 11.4.3 FinVector Viral Vector and Plasmid DNA Introduction
      • 11.4.4 FinVector Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 11.4.5 FinVector Recent Development and Reaction to COVID-19
    • 11.5 Lonza
      • 11.5.1 Lonza Company Details
      • 11.5.2 Lonza Business Overview and Its Total Revenue
      • 11.5.3 Lonza Viral Vector and Plasmid DNA Introduction
      • 11.5.4 Lonza Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 11.5.5 Lonza Recent Development and Reaction to COVID-19
    • 11.6 BioReliance
      • 11.6.1 BioReliance Company Details
      • 11.6.2 BioReliance Business Overview and Its Total Revenue
      • 11.6.3 BioReliance Viral Vector and Plasmid DNA Introduction
      • 11.6.4 BioReliance Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 11.6.5 BioReliance Recent Development and Reaction to COVID-19
    • 11.7 MolMed
      • 11.7.1 MolMed Company Details
      • 11.7.2 MolMed Business Overview and Its Total Revenue
      • 11.7.3 MolMed Viral Vector and Plasmid DNA Introduction
      • 11.7.4 MolMed Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 11.7.5 MolMed Recent Development and Reaction to COVID-19
    • 11.8 FUJIFILM Diosynth Biotechnologies
      • 11.8.1 FUJIFILM Diosynth Biotechnologies Company Details
      • 11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview and Its Total Revenue
      • 11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Introduction
      • 11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 11.8.5 FUJIFILM Diosynth Biotechnologies Recent Development and Reaction to COVID-19
    • 11.9 UniQure
      • 11.9.1 UniQure Company Details
      • 11.9.2 UniQure Business Overview and Its Total Revenue
      • 11.9.3 UniQure Viral Vector and Plasmid DNA Introduction
      • 11.9.4 UniQure Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 11.9.5 UniQure Recent Development and Reaction to COVID-19
    • 11.10 Aldevron
      • 11.10.1 Aldevron Company Details
      • 11.10.2 Aldevron Business Overview and Its Total Revenue
      • 11.10.3 Aldevron Viral Vector and Plasmid DNA Introduction
      • 11.10.4 Aldevron Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 11.10.5 Aldevron Recent Development and Reaction to COVID-19
    • 11.11 Richter-Helm
      • 10.11.1 Richter-Helm Company Details
      • 10.11.2 Richter-Helm Business Overview and Its Total Revenue
      • 10.11.3 Richter-Helm Viral Vector and Plasmid DNA Introduction
      • 10.11.4 Richter-Helm Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 10.11.5 Richter-Helm Recent Development and Reaction to COVID-19
    • 11.12 Eurogentec
      • 10.12.1 Eurogentec Company Details
      • 10.12.2 Eurogentec Business Overview and Its Total Revenue
      • 10.12.3 Eurogentec Viral Vector and Plasmid DNA Introduction
      • 10.12.4 Eurogentec Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 10.12.5 Eurogentec Recent Development and Reaction to COVID-19
    • 11.13 OBiO Technology
      • 10.13.1 OBiO Technology Company Details
      • 10.13.2 OBiO Technology Business Overview and Its Total Revenue
      • 10.13.3 OBiO Technology Viral Vector and Plasmid DNA Introduction
      • 10.13.4 OBiO Technology Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 10.13.5 OBiO Technology Recent Development and Reaction to COVID-19
    • 11.14 Yposkesi
      • 10.14.1 Yposkesi Company Details
      • 10.14.2 Yposkesi Business Overview and Its Total Revenue
      • 10.14.3 Yposkesi Viral Vector and Plasmid DNA Introduction
      • 10.14.4 Yposkesi Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 10.14.5 Yposkesi Recent Development and Reaction to COVID-19
    • 11.15 Cell and Gene Therapy Catapult
      • 10.15.1 Cell and Gene Therapy Catapult Company Details
      • 10.15.2 Cell and Gene Therapy Catapult Business Overview and Its Total Revenue
      • 10.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Introduction
      • 10.15.4 Cell and Gene Therapy Catapult Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 10.15.5 Cell and Gene Therapy Catapult Recent Development and Reaction to COVID-19
    • 11.16 MassBiologics
      • 10.16.1 MassBiologics Company Details
      • 10.16.2 MassBiologics Business Overview and Its Total Revenue
      • 10.16.3 MassBiologics Viral Vector and Plasmid DNA Introduction
      • 10.16.4 MassBiologics Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 10.16.5 MassBiologics Recent Development and Reaction to COVID-19
    • 11.17 Biovian
      • 10.17.1 Biovian Company Details
      • 10.17.2 Biovian Business Overview and Its Total Revenue
      • 10.17.3 Biovian Viral Vector and Plasmid DNA Introduction
      • 10.17.4 Biovian Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 10.17.5 Biovian Recent Development and Reaction to COVID-19
    • 11.18 VGXI
      • 10.18.1 VGXI Company Details
      • 10.18.2 VGXI Business Overview and Its Total Revenue
      • 10.18.3 VGXI Viral Vector and Plasmid DNA Introduction
      • 10.18.4 VGXI Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 10.18.5 VGXI Recent Development and Reaction to COVID-19
    • 11.19 Gene Synthesis
      • 10.19.1 Gene Synthesis Company Details
      • 10.19.2 Gene Synthesis Business Overview and Its Total Revenue
      • 10.19.3 Gene Synthesis Viral Vector and Plasmid DNA Introduction
      • 10.19.4 Gene Synthesis Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 10.19.5 Gene Synthesis Recent Development and Reaction to COVID-19
    • 11.20 PlasmidFactory
      • 10.20.1 PlasmidFactory Company Details
      • 10.20.2 PlasmidFactory Business Overview and Its Total Revenue
      • 10.20.3 PlasmidFactory Viral Vector and Plasmid DNA Introduction
      • 10.20.4 PlasmidFactory Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 10.20.5 PlasmidFactory Recent Development and Reaction to COVID-19
    • 11.21 Jikai Gene
      • 10.21.1 Jikai Gene Company Details
      • 10.21.2 Jikai Gene Business Overview and Its Total Revenue
      • 10.21.3 Jikai Gene Viral Vector and Plasmid DNA Introduction
      • 10.21.4 Jikai Gene Revenue in Viral Vector and Plasmid DNA Business (2015-2020)
      • 10.21.5 Jikai Gene Recent Development and Reaction to COVID-19

    12Analyst's Viewpoints/Conclusions

      13Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
        • 13.1.2 Data Source
      • 13.2 Disclaimer

      Viral Vector and Plasmid DNA market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Viral Vector and Plasmid DNA market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
      Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Viral Vector and Plasmid DNA market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
      This report also analyzes the impact of Coronavirus COVID-19 on the Viral Vector and Plasmid DNA industry.

      The key players covered in this study
      Brammer Bio
      Oxford BioMedica
      Cobra Biologics
      FinVector
      Lonza
      BioReliance
      MolMed
      FUJIFILM Diosynth Biotechnologies
      UniQure
      Aldevron
      Richter-Helm
      Eurogentec
      OBiO Technology
      Yposkesi
      Cell and Gene Therapy Catapult
      MassBiologics
      Biovian
      VGXI
      Gene Synthesis
      PlasmidFactory
      Jikai Gene

      Market segment by Type, the product can be split into
      Plasmid DNA
      Viral Vector
      Market segment by Application, split into
      Cancer
      Virus Infection
      Hereditary Disease

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      India

      The study objectives of this report are:
      To analyze global Viral Vector and Plasmid DNA status, future forecast, growth opportunity, key market and key players.
      To present the Viral Vector and Plasmid DNA development in North America, Europe, China, Japan and India.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Viral Vector and Plasmid DNA are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.



      Summary:
      Viral Vector and Plasmid DNA Market Research Report is about Viral Vector and Plasmid DNA Industry study. Get complete Viral Vector and Plasmid DNA market research report published after Market Study, Industrial Analysis with Trends & Statistics. Viral Vector and Plasmid DNA Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED